CLINICAL_TRIALS
trial_result
· 2021-04-12
Clinical Trial Update: Evaluation of Doxazosin to Alter the Abuse of Oxycodone [Phase 2]
Summary
Phase 2 trial evaluating doxazosin to alter abuse of oxycodone in opioid-use disorder ended (terminated) with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: New York State Psychiatric Institute | Conditions: Opioid-use Disorder | Phase 2 | Status: TERMINATED | Results posted: 2021-04-12